HPTN Studies

Our studies strive to prevent HIV infection through the use of antiretroviral drugs, interventions for substance use, behavioral risk reduction, and structural interventions. 

HPTN research studies are developed by protocol teams that include CTU investigators and recognized experts in HIV prevention. As study protocols are developed, they undergo a rigorous intra- and extra-Network review process that ensures compliance with current ethical guidelines and regulatory procedures. Each Study Protocol is available once version 1.0 is approved and distributed to the performance sites.

Study Snapshot

Study Timelines

 

Filter studies by:

HPTN 050

Phase I Safety and Acceptability Study of the Vaginal Microbicide Agent PMPA Gel

Concluded

Microbicides

HPTN 036

HIV Prevalence, Incidence, and HSV-2 Prevalence Among High-Risk MSM in Perú

Concluded

STD Control

HPTN 034 (10199)

HIV Incidence and Participant Retention Protocol, Pune, India

Concluded

Other

HPTN 047

A Phase I Safety and Acceptability Study of the Investigational Vaginal Microbicide PRO 2000/5 Gel (P)

Concluded

Microbicides

HPTN 032

Male Tolerance Study of BufferGel and PRO 2000/5 Gel (P)

Concluded

Microbicides

HPTN 027 (10141)

A Phase I Study to Evaluate the Safety and Immunogenicity of ALVAC-HIV vCP1521 in Infants Born to HIV-1 Infected Women in Uganda

Concluded

Perinatal

HIVNET 016A

Condom Promotion and Counseling Study

Concluded

Microbicides

HIVNET 015

EXPLORE: A Randomized Clinical Trial of the Efficacy of a Behavioral Intervention to Prevent Acquisition of HIV among Men who have Sex with Men (MSM)

Concluded

Behavioral